IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v594y2021i7861d10.1038_s41586-021-03512-4.html
   My bibliography  Save this article

AI-based pathology predicts origins for cancers of unknown primary

Author

Listed:
  • Ming Y. Lu

    (Harvard Medical School
    Broad Institute of Harvard and MIT
    Dana-Farber Cancer Institute)

  • Tiffany Y. Chen

    (Harvard Medical School
    Broad Institute of Harvard and MIT)

  • Drew F. K. Williamson

    (Harvard Medical School
    Broad Institute of Harvard and MIT)

  • Melissa Zhao

    (Harvard Medical School)

  • Maha Shady

    (Harvard Medical School
    Broad Institute of Harvard and MIT
    Dana-Farber Cancer Institute
    Harvard Medical School)

  • Jana Lipkova

    (Harvard Medical School
    Broad Institute of Harvard and MIT
    Dana-Farber Cancer Institute)

  • Faisal Mahmood

    (Harvard Medical School
    Broad Institute of Harvard and MIT
    Dana-Farber Cancer Institute)

Abstract

Cancer of unknown primary (CUP) origin is an enigmatic group of diagnoses in which the primary anatomical site of tumour origin cannot be determined1,2. This poses a considerable challenge, as modern therapeutics are predominantly specific to the primary tumour3. Recent research has focused on using genomics and transcriptomics to identify the origin of a tumour4–9. However, genomic testing is not always performed and lacks clinical penetration in low-resource settings. Here, to overcome these challenges, we present a deep-learning-based algorithm—Tumour Origin Assessment via Deep Learning (TOAD)—that can provide a differential diagnosis for the origin of the primary tumour using routinely acquired histology slides. We used whole-slide images of tumours with known primary origins to train a model that simultaneously identifies the tumour as primary or metastatic and predicts its site of origin. On our held-out test set of tumours with known primary origins, the model achieved a top-1 accuracy of 0.83 and a top-3 accuracy of 0.96, whereas on our external test set it achieved top-1 and top-3 accuracies of 0.80 and 0.93, respectively. We further curated a dataset of 317 cases of CUP for which a differential diagnosis was assigned. Our model predictions resulted in concordance for 61% of cases and a top-3 agreement of 82%. TOAD can be used as an assistive tool to assign a differential diagnosis to complicated cases of metastatic tumours and CUPs and could be used in conjunction with or in lieu of ancillary tests and extensive diagnostic work-ups to reduce the occurrence of CUP.

Suggested Citation

  • Ming Y. Lu & Tiffany Y. Chen & Drew F. K. Williamson & Melissa Zhao & Maha Shady & Jana Lipkova & Faisal Mahmood, 2021. "AI-based pathology predicts origins for cancers of unknown primary," Nature, Nature, vol. 594(7861), pages 106-110, June.
  • Handle: RePEc:nat:nature:v:594:y:2021:i:7861:d:10.1038_s41586-021-03512-4
    DOI: 10.1038/s41586-021-03512-4
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-021-03512-4
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/s41586-021-03512-4?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Shirong Zhang & Shutao He & Xin Zhu & Yunfei Wang & Qionghuan Xie & Xianrang Song & Chunwei Xu & Wenxian Wang & Ligang Xing & Chengqing Xia & Qian Wang & Wenfeng Li & Xiaochen Zhang & Jinming Yu & She, 2023. "DNA methylation profiling to determine the primary sites of metastatic cancers using formalin-fixed paraffin-embedded tissues," Nature Communications, Nature, vol. 14(1), pages 1-11, December.
    2. Weiwei Wang & Yuanshen Zhao & Lianghong Teng & Jing Yan & Yang Guo & Yuning Qiu & Yuchen Ji & Bin Yu & Dongling Pei & Wenchao Duan & Minkai Wang & Li Wang & Jingxian Duan & Qiuchang Sun & Shengnan Wan, 2023. "Neuropathologist-level integrated classification of adult-type diffuse gliomas using deep learning from whole-slide pathological images," Nature Communications, Nature, vol. 14(1), pages 1-11, December.
    3. David L. Hölscher & Nassim Bouteldja & Mehdi Joodaki & Maria L. Russo & Yu-Chia Lan & Alireza Vafaei Sadr & Mingbo Cheng & Vladimir Tesar & Saskia V. Stillfried & Barbara M. Klinkhammer & Jonathan Bar, 2023. "Next-Generation Morphometry for pathomics-data mining in histopathology," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    4. Alicia-Marie Conway & Simon P. Pearce & Alexandra Clipson & Steven M. Hill & Francesca Chemi & Dan Slane-Tan & Saba Ferdous & A. S. Md Mukarram Hossain & Katarzyna Kamieniecka & Daniel J. White & Clai, 2024. "A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary," Nature Communications, Nature, vol. 15(1), pages 1-12, December.
    5. Luan Nguyen & Arne Hoeck & Edwin Cuppen, 2022. "Machine learning-based tissue of origin classification for cancer of unknown primary diagnostics using genome-wide mutation features," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    6. Md Tauhidul Islam & Zixia Zhou & Hongyi Ren & Masoud Badiei Khuzani & Daniel Kapp & James Zou & Lu Tian & Joseph C. Liao & Lei Xing, 2023. "Revealing hidden patterns in deep neural network feature space continuum via manifold learning," Nature Communications, Nature, vol. 14(1), pages 1-20, December.
    7. Kang-Bo Huang & Cheng-Peng Gui & Yun-Ze Xu & Xue-Song Li & Hong-Wei Zhao & Jia-Zheng Cao & Yu-Hang Chen & Yi-Hui Pan & Bing Liao & Yun Cao & Xin-Ke Zhang & Hui Han & Fang-Jian Zhou & Ran-Yi Liu & Wen-, 2024. "A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma," Nature Communications, Nature, vol. 15(1), pages 1-12, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:594:y:2021:i:7861:d:10.1038_s41586-021-03512-4. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.